Research Associate at Fox Chase Chemical Diversity Center Inc.
Quality Control Associate 2
August 2014 to December 2014
January 2005 to December 2007
LifeSpan BioSciences, Inc.
October 2000 to April 2003
University of Washington, Neurology
Research Scientist 2
April 2012 to September 2012
Greater Seattle Area
University of Washington, Genome Sciences
Research Scientist Assistant
October 2003 to January 2005
Fox Chase Chemical Diversity Center Inc.
Yale University School of Medicine
Research Assistant 2
May 2015 to August 2017
New Haven, Connecticut
Senior Research Associate
January 2008 to March 2012
Greater Seattle Area
Cancer immunotherapy using lentiviral vectors. Phase 1 clinical studies of LV305, targeting cancer antigen NY-ESO-1. Cancer immunotherapy using lentiviral vectors. Phase 1 clinical studies of LV305, targeting cancer antigen NY-ESO-1.
What company does Amy Banks work for?
Amy Banks works for Immune Design
What is Amy Banks's role at Immune Design?
Amy Banks is Quality Control Associate 2
What industry does Amy Banks work in?
Amy Banks works in the Biotechnology industry.
Quality Control Associate 2 @ Immune Design Cancer immunotherapy using lentiviral vectors. Phase 1 clinical studies of LV305, targeting cancer antigen NY-ESO-1. From August 2014 to December 2014 (5 months) Seattle, WAResearch Associate @ Illumigen Biosciences rOAS Program: pre-clinical development of a protein therapeutic for the treatment of hepatitis C virus infection. This company closed in 2007. From January 2005 to December 2007 (3 years) Seattle, WAScientific Editor @ LifeSpan BioSciences, Inc. Contract Research Organization (CRO) with a focus on protein localization in human diseased tissues by immunohistochemistry. From October 2000 to April 2003 (2 years 7 months) Seattle, WAResearch Scientist 2 @ University of Washington, Neurology Jeff Chamberlain lab: using gene therapy (AAV) to treat muscular dystrophy in animal models. From April 2012 to September 2012 (6 months) Greater Seattle AreaResearch Scientist Assistant @ University of Washington, Genome Sciences Debbie Nickerson lab: high-throughput sequencing to identify SNPs in environmental response genes within the human genome. From October 2003 to January 2005 (1 year 4 months) Seattle, WAResearch Associate @ Fox Chase Chemical Diversity Center Inc. Researching the expression and trafficking of the TDP-43 protein, with the goal of discovering a small molecule therapeutic for ALS and dementia. Doylestown, PennsylvaniaResearch Assistant 2 @ Yale University School of Medicine Used shRNA and CRISPR/Cas9 expressing lentiviral vectors screenings strategies for cancer research, with specific interest in KRas mutant carcinomas. From May 2015 to August 2017 (2 years 4 months) New Haven, ConnecticutSenior Research Associate @ Kineta, Inc. RIG-I Program: drug discovery to identify small molecules that induce the innate immune antiviral response, in particular the RIG-I pathway.ShK-186 (Dalazatide) Program: peptide inhibitor of Kv1.3 channel, developed as a therapeutic for autoimmune diseases. Phase 1 completed in 2014. From January 2008 to March 2012 (4 years 3 months) Greater Seattle Area
Introversion (I), Sensing (S), Feeling (F), Judging (J)
2 year(s), 0 month(s)
There's 100% chance that Amy Banks is seeking for new opportunities
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 400K users from
76% of Fortune 500 companies
The most accurate data ever
Hire Anyone, Anywhere
with ContactOut today
Making remote or global hires? We can help.
No credit card required